Home PR Newswire
Wednesday, June 24, 2026
21.1
C
Bengaluru
Hot topics
Geo-Fencing / Shadow Messaging – Hook for Pharma Marketers
In the dynamic world of pharmaceutical marketing, staying ahead of the curve is essential for success. As technology continues to evolve, so do the opportunities for innovative campaigns. One area where pharma marketers can make a significant impact is in raising awareness about non-communicable diseases (NCDs) and promoting real-world studies and clinical trials.
Covid-19 Impact on Indian Pharma Revenues, Field Force, Doctors – Sunil Attavar, CMD Group Pharma
This is the third and final part of MedicinMan...
What pharma marketers get wrong about digital
Marketers often think that everything is new in the digital world. They have simply forgotten the first principle, which is to serve the customers – to have a customer-centric view and not a product-centric one.
A Social Experiment
Articles by K. Hariram, Vivek Hattangadi, Hanno Wolfram, RB Balakrishna and Rajiv Jayaraman
Customer Engagement and Experience are the New Differentiators
At the IDMA Marketing and Sales Conference in Mumbai...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
Hot topics
Track and Trace: Indian Pharma – Current and Future Applicability
Pharmaceutical companies must contend with challenges from supply chain lapses (theft, diversion, S.O.P. deviations, product recalls, reverse logistics etc.) counterfeiting and stringent regulations. These challenges get compounded when dealing across the states and country business operations, besides that not only impact tangible profits but also the intangible brand credibility. In this context, there is also a credible increase in public awareness about the genuineness of medicine (in particular medicine that require cold chain) and their predictability of clinical outcomes.
Providing visibility and full traceability becomes a paramount importance to both the Industry and the Govt. – A fool proof solution not only brings transparency in the system, but can also be a key differentiator, and undoubtedly can create immense opportunities for a competitive advantage.
Why Pharma Field Force Fails: The Missing MAP of Motivation
Executive Summary
Most healthcare organizations fail at execution, not...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
When drones first appeared on battlefields, military establishments reacted...
Boehringer Ingelheim India focuses on partnerships in NCD management
Addressing the media at a roundtable this morning, Vani Manja, Managing Director, Boehringer Ingelheim India said, “Boehringer Ingelheim India aspires to be amongst the top five multinational pharmaceutical companies in India over the next few years. We have been enabling access to our innovator products to patients across India and the neighbouring markets in the diabetes, cardiovascular, stroke and respiratory diseases segments. Our plan in these therapy areas is to build sustainable partnerships to ensure an ecosystem of access and care for patients. We have initiated action in that direction.”
Indian Pharma October 2025 Sales Data
1. Overall Market Growth & Trends (IPM Key Highlights):
Robust...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Newsletter
Get important news delivered directly to your inbox and stay connected!